Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	delayed rectifier potassium channel activity	KCNA2 KCNA3 KCNA4 KCNA6 KCNA7	5.49e-06	28	186	5	GO:0005251
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	RALGAPA1 IPO7 DOCK8 GBP1 HMGCR ANKRD27 ARHGAP22 ARHGAP5 SRGAP1 TBC1D14 EPS8L3 PLCG1 HERC2 RIC1 RASGRP2	8.48e-05	507	186	15	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	RALGAPA1 IPO7 DOCK8 GBP1 HMGCR ANKRD27 ARHGAP22 ARHGAP5 SRGAP1 TBC1D14 EPS8L3 PLCG1 HERC2 RIC1 RASGRP2	8.48e-05	507	186	15	GO:0030695
GeneOntologyMolecularFunction	nicotinic acid receptor activity	HCAR2 HCAR3	8.63e-05	2	186	2	GO:0070553
GeneOntologyMolecularFunction	monoatomic cation channel activity	TMEM63C PKD2L1 PANX3 KCNA2 KCNA3 KCNA4 KCNA6 PKD2L2 KCNA7 PKD2 UNC80 SLC4A11	9.40e-05	343	186	12	GO:0005261
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	PKD2L1 SLC30A1 PANX3 LETM1 KCNA2 KCNA3 KCNA4 SLC30A5 KCNA6 PKD2L2 KCNA7 PKD2 SLC13A5 SLC4A11	1.22e-04	465	186	14	GO:0046873
GeneOntologyMolecularFunction	potassium channel activity	PKD2L1 KCNA2 KCNA3 KCNA4 KCNA6 KCNA7 PKD2	1.99e-04	128	186	7	GO:0005267
GeneOntologyMolecularFunction	hydrolase activity, acting on ester bonds	EME1 PNLIP ERN1 CILP POLD1 PDE10A PLA2G4E OGG1 DICER1 PPP1CA PPP1CC PIKFYVE PNPLA6 PDP1 MTM1 DUSP16 MTMR3 PLCG1 ILKAP	2.00e-04	807	186	19	GO:0016788
GeneOntologyMolecularFunction	histone H2AXS139 kinase activity	ATR PRKDC	2.57e-04	3	186	2	GO:0035979
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	GLRA3 TMEM63C PKD2L1 SLC30A1 ANKH PANX3 LETM1 SLC4A2 KCNA2 KCNA3 KCNA4 SLC30A5 KCNA6 PKD2L2 KCNA7 PKD2 SLC13A5 SLC4A11	2.67e-04	758	186	18	GO:0015318
GeneOntologyMolecularFunction	dynein intermediate chain binding	DYNC2H1 DNAH8 HTT DNAH11	3.79e-04	37	186	4	GO:0045505
GeneOntologyMolecularFunction	monoatomic ion channel activity	GLRA3 TMEM63C PKD2L1 PANX3 KCNA2 KCNA3 KCNA4 KCNA6 PKD2L2 KCNA7 PKD2 UNC80 SLC4A11	3.84e-04	459	186	13	GO:0005216
GeneOntologyMolecularFunction	voltage-gated potassium channel activity	KCNA2 KCNA3 KCNA4 KCNA6 KCNA7 PKD2	3.87e-04	102	186	6	GO:0005249
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate phosphatase activity	PIKFYVE MTM1 MTMR3	4.07e-04	16	186	3	GO:0106018
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	GLRA3 TMEM63C PKD2L1 SLC30A1 PANX3 LETM1 SLC4A2 KCNA2 KCNA3 KCNA4 SLC30A5 KCNA6 PKD2L2 KCNA7 PKD2 SLC13A5 UNC80 SLC4A11	4.57e-04	793	186	18	GO:0015075
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	TMEM63C PKD2L1 SLC30A1 PANX3 LETM1 KCNA2 KCNA3 KCNA4 SLC30A5 KCNA6 PKD2L2 KCNA7 PKD2 SLC13A5 UNC80 SLC4A11	5.03e-04	664	186	16	GO:0008324
GeneOntologyMolecularFunction	protein serine/threonine phosphatase activity	PPP1CA PPP1CC PDP1 DUSP16 MTMR3 ILKAP	5.52e-04	109	186	6	GO:0004722
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DYNC2H1 DNAH8 DNAH11	5.85e-04	18	186	3	GO:0008569
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	TMEM63C PKD2L1 SLC30A1 PANX3 LETM1 KCNA2 KCNA3 KCNA4 SLC30A5 KCNA6 PKD2L2 KCNA7 PKD2 SLC13A5 SLC4A11	8.10e-04	627	186	15	GO:0022890
GeneOntologyMolecularFunction	phospholipase A2 inhibitor activity	ANXA3 SCGB1A1	8.47e-04	5	186	2	GO:0019834
GeneOntologyMolecularFunction	histone H2AX kinase activity	ATR PRKDC	8.47e-04	5	186	2	GO:0141003
GeneOntologyMolecularFunction	zinc:proton antiporter activity	SLC30A1 SLC30A5	8.47e-04	5	186	2	GO:0140826
GeneOntologyMolecularFunction	transporter activity	GLRA3 TMEM63C PKD2L1 MFSD4A SLC7A6 SLC30A1 ATP10A ANKH PANX3 LETM1 SLC4A2 C2CD2L KCNA2 KCNA3 KCNA4 SLC30A5 KCNA6 PKD2L2 KCNA7 PKD2 SLC13A5 ATG9A UNC80 SLC4A11	9.25e-04	1289	186	24	GO:0005215
GeneOntologyMolecularFunction	potassium ion transmembrane transporter activity	PKD2L1 KCNA2 KCNA3 KCNA4 KCNA6 KCNA7 PKD2	9.84e-04	167	186	7	GO:0015079
GeneOntologyMolecularFunction	phosphoric ester hydrolase activity	CILP PDE10A PPP1CA PPP1CC PIKFYVE PDP1 MTM1 DUSP16 MTMR3 PLCG1 ILKAP	1.03e-03	386	186	11	GO:0042578
GeneOntologyMolecularFunction	nucleotide receptor activity	HCAR2 GPR34 HCAR3	1.07e-03	22	186	3	GO:0016502
GeneOntologyMolecularFunction	purinergic nucleotide receptor activity	HCAR2 GPR34 HCAR3	1.07e-03	22	186	3	GO:0001614
GeneOntologyMolecularFunction	channel activity	GLRA3 TMEM63C PKD2L1 PANX3 KCNA2 KCNA3 KCNA4 KCNA6 PKD2L2 KCNA7 PKD2 UNC80 SLC4A11	1.32e-03	525	186	13	GO:0015267
GeneOntologyMolecularFunction	passive transmembrane transporter activity	GLRA3 TMEM63C PKD2L1 PANX3 KCNA2 KCNA3 KCNA4 KCNA6 PKD2L2 KCNA7 PKD2 UNC80 SLC4A11	1.35e-03	526	186	13	GO:0022803
GeneOntologyMolecularFunction	phosphatase activity	CILP PPP1CA PPP1CC PIKFYVE PDP1 MTM1 DUSP16 MTMR3 ILKAP	1.52e-03	287	186	9	GO:0016791
GeneOntologyMolecularFunction	antiporter activity	SLC7A6 SLC30A1 LETM1 SLC4A2 SLC30A5 SLC4A11	1.88e-03	138	186	6	GO:0015297
GeneOntologyMolecularFunction	metal cation:proton antiporter activity	SLC30A1 LETM1 SLC30A5	1.97e-03	27	186	3	GO:0051139
GeneOntologyMolecularFunction	outward rectifier potassium channel activity	KCNA2 KCNA3 PKD2	1.97e-03	27	186	3	GO:0015271
GeneOntologyMolecularFunction	phosphatidylinositol bisphosphate phosphatase activity	PIKFYVE MTM1 MTMR3	1.97e-03	27	186	3	GO:0034593
GeneOntologyMolecularFunction	phosphoprotein phosphatase activity	PPP1CA PPP1CC PDP1 MTM1 DUSP16 MTMR3 ILKAP	2.00e-03	189	186	7	GO:0004721
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DYNC2H1 DNAH8 DNAH11	2.19e-03	28	186	3	GO:0051959
GeneOntologyMolecularFunction	class I DNA-(apurinic or apyrimidinic site) endonuclease activity	NEIL1 OGG1	2.33e-03	8	186	2	GO:0140078
GeneOntologyMolecularFunction	C-methyltransferase activity	COQ5 TRMT2B	2.33e-03	8	186	2	GO:0008169
GeneOntologyMolecularFunction	phosphatidylinositol phosphate phosphatase activity	PIKFYVE MTM1 MTMR3	2.68e-03	30	186	3	GO:0052866
GeneOntologyMolecularFunction	alpha-actinin binding	PKD2L1 ALMS1 PKD2	2.95e-03	31	186	3	GO:0051393
GeneOntologyMolecularFunction	arginine binding	SLC7A6 NOS3	2.98e-03	9	186	2	GO:0034618
GeneOntologyMolecularFunction	voltage-gated monoatomic cation channel activity	KCNA2 KCNA3 KCNA4 KCNA6 KCNA7 PKD2	3.04e-03	152	186	6	GO:0022843
GeneOntologyBiologicalProcess	protein homooligomerization	GLRA3 PKD2L1 BEND3 LETM1 NLRP6 MLKL KCNA2 KCNA3 KCNA4 KCNA6 KCNA7 PKD2	8.47e-07	224	184	12	GO:0051260
GeneOntologyBiologicalProcess	autophagosome organization	SPG11 RB1CC1 PIKFYVE AP5Z1 MTM1 TBC1D14 MTMR3 ZFYVE26 ATG9A	2.40e-06	129	184	9	GO:1905037
GeneOntologyBiologicalProcess	protein complex oligomerization	GLRA3 PKD2L1 BEND3 LETM1 NLRP6 MLKL KCNA2 KCNA3 KCNA4 KCNA6 KCNA7 PKD2	1.48e-05	296	184	12	GO:0051259
MousePheno	decreased brain weight	ATR SPG11 THOC2 CIT ADCY3 PIKFYVE KIF14 ZFYVE26	1.28e-05	106	143	8	MP:0002175
Domain	K_chnl_volt-dep_Kv1	KCNA2 KCNA3 KCNA4 KCNA6 KCNA7	4.94e-09	8	185	5	IPR003972
Domain	ARM-type_fold	RALGAPA1 ARMC7 IPO7 ATR HGH1 INTS7 DOCK8 RTTN INTS1 MROH5 WDFY4 URB1 PELP1 CLTC PRKDC HTT PPP6R3	4.90e-08	339	185	17	IPR016024
Domain	ARM-like	ARMC7 IPO7 ATR HGH1 INTS7 DOCK8 RTTN MROH5 WDFY4 PELP1 AP5Z1 PRKDC MED12 HTT PPP6R3	8.27e-08	270	185	15	IPR011989
Domain	-	ARMC7 IPO7 ATR HGH1 INTS7 RTTN MROH5 WDFY4 AP5Z1 PRKDC MED12 HTT	2.26e-06	222	185	12	1.25.10.10
Domain	K_chnl_volt-dep_Kv	KCNA2 KCNA3 KCNA4 KCNA6 KCNA7	6.11e-06	27	185	5	IPR003968
Domain	PKD_2	PKD2L1 PKD2L2 PKD2	9.42e-06	5	185	3	IPR003915
Domain	VG_K_chnl	KCNA2 KCNA3 KCNA4 KCNA6 KCNA7	1.71e-05	33	185	5	IPR028325
Domain	Channel_four-helix_dom	KCNA2 KCNA3 KCNA4 KCNA6 KCNA7 PKD2	2.08e-05	57	185	6	IPR027359
Domain	-	KCNA2 KCNA3 KCNA4 KCNA6 KCNA7 PKD2	2.08e-05	57	185	6	1.20.120.350
Domain	Ski_Sno	SKI SKIL DACH2	3.25e-05	7	185	3	PF02437
Domain	-	SKI SKIL DACH2	3.25e-05	7	185	3	3.10.260.20
Domain	Transform_Ski	SKI SKIL DACH2	3.25e-05	7	185	3	IPR003380
Domain	DHC_N1	DYNC2H1 DNAH8 DNAH11	5.16e-05	8	185	3	PF08385
Domain	Dynein_heavy_dom-1	DYNC2H1 DNAH8 DNAH11	5.16e-05	8	185	3	IPR013594
Domain	HCAR2/3_rcpt	HCAR2 HCAR3	9.76e-05	2	185	2	IPR028017
Domain	DNA-bd_dom_put	SKI SKIL DACH2	1.49e-04	11	185	3	IPR009061
Domain	PKD_channel	PKD2L1 PKD2L2 PKD2	1.49e-04	11	185	3	PF08016
Domain	PKD1_2_channel	PKD2L1 PKD2L2 PKD2	1.49e-04	11	185	3	IPR013122
Domain	BTB_2	KCNA2 KCNA3 KCNA4 KCNA6 KCNA7	1.76e-04	53	185	5	PF02214
Domain	T1-type_BTB	KCNA2 KCNA3 KCNA4 KCNA6 KCNA7	1.76e-04	53	185	5	IPR003131
Domain	STPPase_N	PPP1CA PPP1CC	2.91e-04	3	185	2	IPR031675
Domain	STPPase_N	PPP1CA PPP1CC	2.91e-04	3	185	2	PF16891
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DNAH8 DNAH11	3.21e-04	14	185	3	IPR024317
Domain	Dynein_HC_stalk	DYNC2H1 DNAH8 DNAH11	3.21e-04	14	185	3	IPR024743
Domain	Dynein_heavy_dom-2	DYNC2H1 DNAH8 DNAH11	3.21e-04	14	185	3	IPR013602
Domain	DHC_N2	DYNC2H1 DNAH8 DNAH11	3.21e-04	14	185	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DYNC2H1 DNAH8 DNAH11	3.21e-04	14	185	3	IPR011704
Domain	TUDOR	TDRD15 TDRKH TDRD6	3.21e-04	14	185	3	PF00567
Domain	MT	DYNC2H1 DNAH8 DNAH11	3.21e-04	14	185	3	PF12777
Domain	AAA_8	DYNC2H1 DNAH8 DNAH11	3.21e-04	14	185	3	PF12780
Domain	AAA_5	DYNC2H1 DNAH8 DNAH11	3.21e-04	14	185	3	PF07728
Domain	DHC_fam	DYNC2H1 DNAH8 DNAH11	3.99e-04	15	185	3	IPR026983
Domain	Dynein_heavy	DYNC2H1 DNAH8 DNAH11	3.99e-04	15	185	3	PF03028
Domain	Dynein_heavy_dom	DYNC2H1 DNAH8 DNAH11	3.99e-04	15	185	3	IPR004273
Domain	Tscrpt_reg_SKI_SnoN	SKI SKIL	5.78e-04	4	185	2	IPR023216
Domain	c-SKI_SMAD_bind	SKI SKIL	5.78e-04	4	185	2	PF08782
Domain	c-SKI_SMAD_bind	SKI SKIL	5.78e-04	4	185	2	SM01046
Domain	c-SKI_SMAD4-bd_dom	SKI SKIL	5.78e-04	4	185	2	IPR014890
Domain	PC1	PKD2L1 PKD2L2	5.78e-04	4	185	2	IPR000434
Domain	ZF_ZZ_2	DYTN ZZEF1 HERC2	6.99e-04	18	185	3	PS50135
Domain	ZF_ZZ_1	DYTN ZZEF1 HERC2	6.99e-04	18	185	3	PS01357
Domain	ZZ	DYTN ZZEF1 HERC2	6.99e-04	18	185	3	PF00569
Domain	Znf_ZZ	DYTN ZZEF1 HERC2	8.24e-04	19	185	3	IPR000433
Domain	ZnF_ZZ	DYTN ZZEF1 HERC2	8.24e-04	19	185	3	SM00291
Domain	FATC	ATR PRKDC	9.57e-04	5	185	2	PF02260
Domain	-	TDRD15 TDRD6	1.43e-03	6	185	2	2.40.50.90
Domain	Staphylococal_nuclease_OB-fold	TDRD15 TDRD6	1.43e-03	6	185	2	IPR016071
Domain	FAT	ATR PRKDC	1.43e-03	6	185	2	PS51189
Domain	FATC	ATR PRKDC	1.43e-03	6	185	2	PS51190
Domain	FAT	ATR PRKDC	1.43e-03	6	185	2	PF02259
Domain	PIK-rel_kinase_FAT	ATR PRKDC	1.43e-03	6	185	2	IPR003151
Domain	FATC_dom	ATR PRKDC	1.43e-03	6	185	2	IPR003152
Domain	PIK_FAT	ATR PRKDC	1.43e-03	6	185	2	IPR014009
Domain	FATC	ATR PRKDC	1.43e-03	6	185	2	SM01343
Domain	TUDOR	TDRD15 TDRKH TDRD6	1.46e-03	23	185	3	PS50304
Domain	APC_su10/DOC_dom	ZZEF1 HERC2	1.98e-03	7	185	2	IPR004939
Domain	DOC	ZZEF1 HERC2	1.98e-03	7	185	2	PS51284
Domain	ANAPC10	ZZEF1 HERC2	1.98e-03	7	185	2	PF03256
Domain	APC10	ZZEF1 HERC2	1.98e-03	7	185	2	SM01337
Domain	TUDOR	TDRD15 TDRKH TDRD6	2.35e-03	27	185	3	SM00333
Pathway	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	KCNA2 KCNA3 KCNA4 KCNA6 KCNA7	4.10e-05	41	134	5	MM14546
Pathway	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	KCNA2 KCNA3 KCNA4 KCNA6 KCNA7	5.19e-05	43	134	5	M1056
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MTG2 RTTN INTS1 TOR4A PLXND1 ZZEF1 TESK1 CIT C2CD2L PIKFYVE PIAS4 URB1 PNPLA6 RPAP1 PLEKHM2 DUSP16 MTMR3 PCNX1 ZFYVE26 LRRC14 PLCG1 PRKDC ATG9A HERC2 MED12 RIC1 HTT	7.37e-11	1105	189	27	35748872
Pubmed	Truncation of the Shaker-like voltage-gated potassium channel, Kv1.1, causes megencephaly.	KCNA2 KCNA3 KCNA4 KCNA6	1.26e-08	6	189	4	14686897
Pubmed	Genomic organization, chromosomal localization, tissue distribution, and biophysical characterization of a novel mammalian Shaker-related voltage-gated potassium channel, Kv1.7.	KCNA2 KCNA3 KCNA6 KCNA7	1.04e-07	9	189	4	9488722
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYH9 IPO7 INTS1 BEND3 THOC2 DICER1 PPP1CA PPP1CC URB1 PELP1 CLTC KIF14 PRKDC HERC2 MED12 HERC5 PPP6R3	1.23e-07	653	189	17	22586326
Pubmed	Polycystin-2 expression and function in adult mouse lacrimal acinar cells.	PKD2L1 PKD2L2 PKD2	1.58e-07	3	189	3	21508103
Pubmed	Developmental expression of voltage-sensitive K+ channels in mouse skeletal muscle and C2C12 cells.	KCNA2 KCNA3 KCNA4 KCNA6	1.73e-07	10	189	4	1383027
Pubmed	Defining the membrane proteome of NK cells.	MYH9 IPO7 DOCK8 POLD1 INTS1 EXT2 PEX11B ITGAL CIT ADCY3 ANKRD27 SLC4A2 PNPLA6 PELP1 CLTC KIF14 ECI2 PRKDC ATG9A HERC2 MED12 ILVBL	4.52e-07	1168	189	22	19946888
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	RALGAPA1 IPO7 HID1 RB1CC1 SLC30A1 LETM1 PPP1CA PPP1CC ARHGAP5 PDP1 MTM1 DUSP16 CLTC MTMR3 FMN2 KIF14 UBR3 HERC2 PPP6R3 ILKAP	1.30e-06	1049	189	20	27880917
Pubmed	A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia.	SPG11 AP5Z1 ZFYVE26	1.57e-06	5	189	3	20613862
Pubmed	RB1CC1 protein positively regulates transforming growth factor-beta signaling through the modulation of Arkadia E3 ubiquitin ligase activity.	RB1CC1 SKI SKIL	1.57e-06	5	189	3	21795712
Pubmed	Polycystin channels and kidney disease.	PKD2L1 PKD2L2 PKD2	1.57e-06	5	189	3	11698076
Pubmed	Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome.	HCAR2 NLRP6 HCAR3	1.57e-06	5	189	3	25828455
Pubmed	Contribution of Kv1.2 voltage-gated potassium channel to D2 autoreceptor regulation of axonal dopamine overflow.	KCNA2 KCNA3 KCNA6	1.57e-06	5	189	3	21233214
Pubmed	Subunit composition of Kv1 channels in human CNS.	KCNA2 KCNA3 KCNA4	1.57e-06	5	189	3	10428084
Pubmed	International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels.	KCNA2 KCNA3 KCNA4 KCNA6 KCNA7	2.53e-06	40	189	5	16382104
Pubmed	Physical mapping of potassium channel gene clusters on mouse chromosomes three and six.	KCNA2 KCNA3 KCNA6	3.12e-06	6	189	3	9286706
Pubmed	PtdIns5P regulation through evolution: roles in membrane trafficking?	PIKFYVE MTM1 MTMR3	3.12e-06	6	189	3	18774718
Pubmed	Differential K+ channel clustering activity of PSD-95 and SAP97, two related membrane-associated putative guanylate kinases.	KCNA2 KCNA3 KCNA4	3.12e-06	6	189	3	8938729
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	PPP1CA PPP1CC DUSP16 LRRTM4 MTMR3 SLC13A5 PCNX1 HERC2 DNAH8 UNC80 DOP1A ILKAP	3.66e-06	420	189	12	28065597
Pubmed	Clustering of Shaker-type K+ channels by interaction with a family of membrane-associated guanylate kinases.	KCNA2 KCNA3 KCNA4	5.44e-06	7	189	3	7477295
Pubmed	Pore size matters for potassium channel conductance.	KCNA2 KCNA4 KCNA6	5.44e-06	7	189	3	27619418
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RALGAPA1 SPG11 PLXND1 SLC7A6 ZZEF1 ANKH DICER1 ANKRD27 AP5Z1 SENP6 PCNX1 MED23 PPP6R3	7.33e-06	529	189	13	14621295
Pubmed	Spatacsin regulates directionality of lysosome trafficking by promoting the degradation of its partner AP5Z1.	SPG11 AP5Z1 ZFYVE26	8.67e-06	8	189	3	37871017
Pubmed	N-terminal PDZ-binding domain in Kv1 potassium channels.	KCNA2 KCNA3 KCNA4	8.67e-06	8	189	3	12435606
Pubmed	An atlas of genetic influences on human blood metabolites.	UGT1A5 PKD2L1 SLC7A6 ANKH UGT1A3 ALMS1 SLC13A5 ECI2	1.02e-05	190	189	8	24816252
Pubmed	Chromosomal mapping in the mouse of eight K(+)-channel genes representing the four Shaker-like subfamilies Shaker, Shab, Shaw, and Shal.	KCNA2 KCNA3 KCNA4 KCNA6	1.15e-05	26	189	4	7905852
Pubmed	Human metabolic individuality in biomedical and pharmaceutical research.	UGT1A5 PKD2L1 SLC7A6 UGT1A3 ALMS1	1.50e-05	57	189	5	21886157
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MYH9 IPO7 ATR CIT DICER1 CLTC PRKDC HERC2	1.60e-05	202	189	8	33005030
Pubmed	Two members of the TRPP family of ion channels, Pkd1l3 and Pkd2l1, are co-expressed in a subset of taste receptor cells.	PKD2L1 PKD2L2 PKD2	1.84e-05	10	189	3	16805797
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	MYH9 IPO7 OGFR ANXA3 MLKL MTM1 CLTC PLCG1 PRKDC HTT	2.07e-05	344	189	10	30333137
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	RALGAPA1 AFTPH IPO7 DYNC2H1 POLD1 COQ5 SPG11 EXT2 RB1CC1 SLC30A1 TIMMDC1 DICER1 LETM1 SLC4A2 PPP1CC URB1 PNPLA6 RPAP1 CLTC HERC2 HERC5 PPP6R3	2.13e-05	1487	189	22	33957083
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RALGAPA1 NEIL1 TMEM63C EVC PDE10A SKI ATP10A ANKH ADCY3 HPS3 PIAS4 PNPLA6 GPR137C TBC1D14 PKD2 MAST1 FOLH1B PLCG1 ERMARD RIC1 HTT DOP1A	2.18e-05	1489	189	22	28611215
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	RALGAPA1 TDRKH SPG11 ANKRD27 HPS3 SLC4A2 PIKFYVE SLC30A5 PLEKHM2 FMN2 ATG9A RIC1	2.26e-05	504	189	12	34432599
Pubmed	Functional proteomics mapping of a human signaling pathway.	A2M DOCK8 PPIL4 SKI SKIL ZZEF1 ANKRD27 PPP1CA PPP1CC PIAS4 ARHGAP5 PELP1 HERC2	2.35e-05	591	189	13	15231748
Pubmed	Voltage-gated potassium channel genes are clustered in paralogous regions of the mouse genome.	KCNA2 KCNA3 KCNA6 KCNA7	2.37e-05	31	189	4	8034307
Pubmed	Hereditary spastic paraplegia with mental impairment and thin corpus callosum in Tunisia: SPG11, SPG15, and further genetic heterogeneity.	SPG11 ZFYVE26	2.94e-05	2	189	2	18332254
Pubmed	Activated niacin receptor HCA2 inhibits chemoattractant-mediated macrophage migration via Gβγ/PKC/ERK1/2 pathway and heterologous receptor desensitization.	HCAR2 HCAR3	2.94e-05	2	189	2	28186140
Pubmed	Variable penetrance of metabolic phenotypes and development of high-fat diet-induced adiposity in NEIL1-deficient mice.	NEIL1 PLXND1	2.94e-05	2	189	2	21285402
Pubmed	Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity.	RB1CC1 PIAS4	2.94e-05	2	189	2	18285457
Pubmed	The Immunometabolomic Interface Receptor Hydroxycarboxylic Acid Receptor 2 Mediates the Therapeutic Effects of Dimethyl Fumarate in Autoantibody-Induced Skin Inflammation.	HCAR2 HCAR3	2.94e-05	2	189	2	30154797
Pubmed	Cloning and characterization of cDNAs encoding mouse Ugt1.6 and rabbit UGT1.6: differential induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin.	UGT1A5 UGT1A3	2.94e-05	2	189	2	8068691
Pubmed	Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A.	PDE10A HTT	2.94e-05	2	189	2	15610167
Pubmed	CCCP-Induced LC3 lipidation depends on Atg9 whereas FIP200/Atg13 and Beclin 1/Atg14 are dispensable.	RB1CC1 ATG9A	2.94e-05	2	189	2	23402761
Pubmed	The role of HCA2 (GPR109A) in regulating macrophage function.	HCAR2 HCAR3	2.94e-05	2	189	2	23882124
Pubmed	Crosstalk between microbiome, regulatory T cells and HCA2 orchestrates the inflammatory response in a murine psoriasis model.	HCAR2 HCAR3	2.94e-05	2	189	2	36891315
Pubmed	Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus.	SKI SKIL	2.94e-05	2	189	2	18261624
Pubmed	Complex formation between proteins encoded by the ski gene family.	SKI SKIL	2.94e-05	2	189	2	8514802
Pubmed	Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a.	HCAR2 HCAR3	2.94e-05	2	189	2	38007572
Pubmed	The LC3 recruitment mechanism is separate from Atg9L1-dependent membrane formation in the autophagic response against Salmonella.	RB1CC1 ATG9A	2.94e-05	2	189	2	21525242
Pubmed	Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE.	HCAR2 HCAR3	2.94e-05	2	189	2	24691444
Pubmed	Butyrate ameliorates caerulein-induced acute pancreatitis and associated intestinal injury by tissue-specific mechanisms.	HCAR2 HCAR3	2.94e-05	2	189	2	31347703
Pubmed	Isolation of human cDNA clones of ski and the ski-related gene, sno.	SKI SKIL	2.94e-05	2	189	2	2762147
Pubmed	Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis.	HCAR2 HCAR3	2.94e-05	2	189	2	30659164
Pubmed	DNA structure-specific priming of ATR activation by DNA-PKcs.	ATR PRKDC	2.94e-05	2	189	2	23897887
Pubmed	Proto-oncogene Sno expression, alternative isoforms and immediate early serum response.	SKI SKIL	2.94e-05	2	189	2	9207045
Pubmed	Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium.	HCAR2 HCAR3	2.94e-05	2	189	2	19223991
Pubmed	Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia.	PKD2 PKHD1	2.94e-05	2	189	2	20634433
Pubmed	Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice.	HCAR2 HCAR3	2.94e-05	2	189	2	23967184
Pubmed	Fibrocystin/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia.	PKD2 PKHD1	2.94e-05	2	189	2	17283055
Pubmed	A novel role of ATG9A and RB1CC1/FIP200 in mediating cell-death checkpoints to repress TNF cytotoxicity.	RB1CC1 ATG9A	2.94e-05	2	189	2	36892222
Pubmed	Involvement of the Niacin Receptor GPR109a in the LocalControl of Glucose Uptake in Small Intestine of Type 2Diabetic Mice.	HCAR2 HCAR3	2.94e-05	2	189	2	26371038
Pubmed	Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease.	HCAR2 HCAR3	2.94e-05	2	189	2	34653248
Pubmed	Phenolic acids suppress adipocyte lipolysis via activation of the nicotinic acid receptor GPR109A (HM74a/PUMA-G).	HCAR2 HCAR3	2.94e-05	2	189	2	19136666
Pubmed	Evidence for the involvement of DNA repair enzyme NEIL1 in nucleotide excision repair of (5'R)- and (5'S)-8,5'-cyclo-2'-deoxyadenosines.	NEIL1 OGG1	2.94e-05	2	189	2	20067321
Pubmed	Hydrophobic pore gates regulate ion permeation in polycystic kidney disease 2 and 2L1 channels.	PKD2L1 PKD2	2.94e-05	2	189	2	29899465
Pubmed	G Protein-Coupled Receptor 109A Maintains the Intestinal Integrity and Protects Against ETEC Mucosal Infection by Promoting IgA Secretion.	HCAR2 HCAR3	2.94e-05	2	189	2	33488584
Pubmed	Lactate-induced activation of HCA2 improves survival in mice with sepsis.	HCAR2 HCAR3	2.94e-05	2	189	2	30951370
Pubmed	LETM1 (leucine zipper-EF-hand-containing transmembrane protein 1) silence reduces the proliferation, invasion, migration and angiogenesis in esophageal squamous cell carcinoma via KIF14 (kinesin family member 14).	LETM1 KIF14	2.94e-05	2	189	2	34605738
Pubmed	Niacin Ameliorates Hepatic Steatosis by Inhibiting De Novo Lipogenesis Via a GPR109A-Mediated PKC-ERK1/2-AMPK Signaling Pathway in C57BL/6 Mice Fed a High-Fat Diet.	HCAR2 HCAR3	2.94e-05	2	189	2	31858105
Pubmed	Impaired mitochondrial dynamics underlie axonal defects in hereditary spastic paraplegias.	AP5Z1 ZFYVE26	2.94e-05	2	189	2	29726929
Pubmed	Exploring the role of the metabolite-sensing receptor GPR109a in diabetic nephropathy.	HCAR2 HCAR3	2.94e-05	2	189	2	32068460
Pubmed	The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome.	HCAR2 HCAR3	2.94e-05	2	189	2	30657794
Pubmed	Melatonin alleviates titanium nanoparticles induced osteolysis via activation of butyrate/GPR109A signaling pathway.	HCAR2 HCAR3	2.94e-05	2	189	2	34092246
Pubmed	An epilepsy-associated KV1.2 charge-transfer-center mutation impairs KV1.2 and KV1.4 trafficking.	KCNA2 KCNA4	2.94e-05	2	189	2	35439054
Pubmed	Molecular identification of high and low affinity receptors for nicotinic acid.	HCAR2 HCAR3	2.94e-05	2	189	2	12522134
Pubmed	Identification of the structural motif responsible for trimeric assembly of the C-terminal regulatory domains of polycystin channels PKD2L1 and PKD2.	PKD2L1 PKD2	2.94e-05	2	189	2	20408813
Pubmed	NMMHC IIA triggers neuronal autophagic cell death by promoting F-actin-dependent ATG9A trafficking in cerebral ischemia/reperfusion.	MYH9 ATG9A	2.94e-05	2	189	2	32513915
Pubmed	G Protein-Coupled Receptor 109A and Host Microbiota Modulate Intestinal Epithelial Integrity During Sepsis.	HCAR2 HCAR3	2.94e-05	2	189	2	30271409
Pubmed	Niacin fine-tunes energy homeostasis through canonical GPR109A signaling.	HCAR2 HCAR3	2.94e-05	2	189	2	30596513
Pubmed	The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer's disease.	HCAR2 HCAR3	2.94e-05	2	189	2	35320002
Pubmed	GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.	HCAR2 HCAR3	2.94e-05	2	189	2	16322797
Pubmed	Nicotinic acid receptor agonists.	HCAR2 HCAR3	2.94e-05	2	189	2	18983141
Pubmed	Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms.	HCAR2 HCAR3	2.94e-05	2	189	2	31366236
Pubmed	Polycystin-2 expression is regulated by a PC2-binding domain in the intracellular portion of fibrocystin.	PKD2 PKHD1	2.94e-05	2	189	2	18782757
Pubmed	ZFYVE26/SPASTIZIN and SPG11/SPATACSIN mutations in hereditary spastic paraplegia types AR-SPG15 and AR-SPG11 have different effects on autophagy and endocytosis.	SPG11 ZFYVE26	2.94e-05	2	189	2	30081747
Pubmed	GPR109A gene deletion ameliorates gonadectomy-induced bone loss in mice.	HCAR2 HCAR3	2.94e-05	2	189	2	35489706
Pubmed	Spermiogenesis is impaired in mice bearing a targeted mutation in the protein phosphatase 1cgamma gene.	PPP1CA PPP1CC	2.94e-05	2	189	2	9882500
Pubmed	SKI controls MDS-associated chronic TGF-β signaling, aberrant splicing, and stem cell fitness.	SKI SKIL	2.94e-05	2	189	2	30249787
Pubmed	TGF-beta repressors SnoN and Ski are implicated in human colorectal carcinogenesis.	SKI SKIL	2.94e-05	2	189	2	19096149
Pubmed	Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-beta resistance, in primary cutaneous melanoma.	SKI SKIL	2.94e-05	2	189	2	18782659
Pubmed	SnoI, a novel alternatively spliced isoform of the ski protooncogene homolog, sno.	SKI SKIL	2.94e-05	2	189	2	8233802
Pubmed	Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis.	HCAR2 HCAR3	2.94e-05	2	189	2	19561068
Pubmed	Oxidatively-induced DNA damage and base excision repair in euthymic patients with bipolar disorder.	NEIL1 OGG1	2.94e-05	2	189	2	29626765
Pubmed	The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival.	HCAR2 HCAR3	2.94e-05	2	189	2	24371223
Pubmed	High dietary niacin may increase prostaglandin formation but does not increase tumor formation in ApcMin/+ mice.	HCAR2 HCAR3	2.94e-05	2	189	2	21774590
Pubmed	GPR109a Regulates Phenotypic and Functional Alterations in Macrophages and the Progression of Type 1 Diabetes.	HCAR2 HCAR3	2.94e-05	2	189	2	36208084
Pubmed	Expression and chromosomal localization of a lymphocyte K+ channel gene.	KCNA2 KCNA3	2.94e-05	2	189	2	2251283
Pubmed	The role of the C-terminus of the human hydroxycarboxylic acid receptors 2 and 3 in G protein activation using Gα-engineered yeast cells.	HCAR2 HCAR3	2.94e-05	2	189	2	26656756
Pubmed	Chromosomal mapping of two members of the human dynein gene family to chromosome regions 7p15 and 11q13 near the deafness loci DFNA 5 and DFNA 11.	DYNC2H1 DNAH11	2.94e-05	2	189	2	9325061
Pubmed	Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation.	HCAR2 HCAR3	2.94e-05	2	189	2	37597514
Interaction	GPR17 interactions	ATR COQ5 INTS1 SPG11 HMGCR MAP3K4 SLC4A2 URB1 SLC30A5 UBR3 PRKDC MED23 HTT DOP1A	2.69e-07	283	180	14	int:GPR17
Interaction	TOP3B interactions	TDRKH MTG2 RTTN INTS1 TOR4A PLXND1 THOC2 ZZEF1 TESK1 CIT C2CD2L PIKFYVE PIAS4 URB1 PNPLA6 RPAP1 PELP1 PLEKHM2 DUSP16 MTMR3 KIF14 PCNX1 ZFYVE26 LRRC14 PLCG1 PRKDC ATG9A HERC2 MED12 RIC1 HTT	6.33e-06	1470	180	31	int:TOP3B
Interaction	NPTN interactions	ATR DYNC2H1 COQ5 INTS1 SPG11 PIKFYVE AP5Z1 KIF14 ZFYVE26 MIEF2 HTT DOP1A	7.97e-06	278	180	12	int:NPTN
Interaction	CTDP1 interactions	INTS7 INTS1 CIT PPP1CA PNPLA6 RPAP1 KIF14 PRKDC MED23 HTT	1.76e-05	207	180	10	int:CTDP1
Interaction	FBXL12 interactions	A2M HGH1 DOCK8 MAST1 ALDH3A1 GPR45	2.97e-05	67	180	6	int:FBXL12
Interaction	BMP2K interactions	MYH9 PPP1CA PPP1CC CLTC KIF14 ATG9A HTT	4.40e-05	105	180	7	int:BMP2K
Interaction	AP3B1 interactions	ATR POLD1 TBC1D32 KCNA3 PELP1 LRRTM4 CLTC KIF14 ATG9A	4.81e-05	187	180	9	int:AP3B1
Interaction	AP3B2 interactions	KCNA3 CLTC KIF14 ATG9A HTT	4.92e-05	45	180	5	int:AP3B2
Interaction	SORBS2 interactions	MYH9 CIT PPP1CA PPP1CC SRGAP1 CLTC KIF14	6.27e-05	111	180	7	int:SORBS2
Interaction	EIF2AK4 interactions	AK9 PPP1CA PPP1CC KCNA3 DUSP16 KIF14	6.55e-05	77	180	6	int:EIF2AK4
Interaction	HSP90B2P interactions	CIT KIF14 HERC2 DOP1A	6.72e-05	25	180	4	int:HSP90B2P
Cytoband	8q11	RB1CC1 PRKDC	2.50e-04	6	189	2	8q11
Cytoband	3p11.1	C3orf38 ZNF654	2.50e-04	6	189	2	3p11.1
Cytoband	12q24.31	HCAR2 COQ5 OGFOD2 HCAR3	3.45e-04	80	189	4	12q24.31
GeneFamily	Potassium voltage-gated channels	KCNA2 KCNA3 KCNA4 KCNA6 KCNA7	5.96e-06	40	118	5	274
GeneFamily	Hydroxy-carboxylic acid receptors	HCAR2 HCAR3	1.26e-04	3	118	2	200
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	DYTN ZZEF1 HERC2	2.06e-04	18	118	3	91
GeneFamily	SKI transcriptional corepressors	SKI SKIL	2.51e-04	4	118	2	748
GeneFamily	Transient receptor potential cation channels	PKD2L1 PKD2L2 PKD2	7.88e-04	28	118	3	249
GeneFamily	Zinc fingers FYVE-type\|Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors	PIKFYVE MTMR3 ZFYVE26	1.07e-03	31	118	3	81
GeneFamily	Tudor domain containing	TDRD15 TDRKH TDRD6	1.79e-03	37	118	3	780
GeneFamily	DNA glycosylases	NEIL1 OGG1	2.24e-03	11	118	2	1024
GeneFamily	Protein phosphatase catalytic subunits\|EF-hand domain containing	PPP1CA PPP1CC	3.14e-03	13	118	2	693
GeneFamily	EF-hand domain containing	CALB1 ZZEF1 LETM1 PKD2 PLCG1 RASGRP2	3.15e-03	219	118	6	863
GeneFamily	Myotubularins\|Phosphoinositide phosphatases	MTM1 MTMR3	4.20e-03	15	118	2	903
GeneFamily	Integrator complex	INTS7 INTS1	4.20e-03	15	118	2	1366
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP22 ARHGAP5 SRGAP1	4.25e-03	50	118	3	721
GeneFamily	Dyneins, axonemal	DNAH8 DNAH11	5.39e-03	17	118	2	536
GeneFamily	Protein phosphatases, Mg2+/Mn2+ dependent	PDP1 ILKAP	5.39e-03	17	118	2	701
GeneFamily	Phospholipases\|C2 domain containing phospholipases	PLA2G4E PLCG1	6.72e-03	19	118	2	832
Coexpression	GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP	CALB1 PNLIP IPO7 ATR ACO1 HERC2P3 KCNA3 KIF14 ILVBL	1.45e-05	198	189	9	M5222
Coexpression	GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN	RALGAPA1 IPO7 BEND3 DUSP16 LRRTM4 PCNX1 LRRC14 ZNF654 DOP1A	1.57e-05	200	189	9	M3491
Coexpression	GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP	IPO7 BEND3 SPG11 C2CD2L PIKFYVE KCNA2 ZFYVE26 LRRC14	2.88e-05	166	189	8	M8987
Coexpression	SOGA_COLORECTAL_CANCER_MYC_UP	ATR POLD1 POLA2 SLC7A6 ADCY3 SLC4A2	2.88e-05	82	189	6	M45007
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	A2M DOCK8 HMGCR SLC7A6 SLC30A1 MAP3K4 URB1 MTM1 CLTC KIF14 PRKDC	4.57e-10	185	189	11	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	A2M DOCK8 SLC7A6 SLC30A1 MAP3K4 URB1 MTM1 CLTC KIF14 PRKDC	7.59e-09	186	189	10	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TDRKH CAPG GPR37L1 PDE10A ITIH5 KCNA2 BRF1 KCNA6	8.90e-07	176	189	8	792f414f5092aba14260b8e16378e793a822498e
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PKD2L1 POLA2 ATP10A ITIH5 KCNA4 DACH2 SRGAP1 FMN2	1.71e-06	192	189	8	ef0aba777072429a6ab7dcfcc305673975946580
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	RALGAPA1 ATR LRRC58 THOC2 CLTC PCNX1 PRKDC MED23	1.78e-06	193	189	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	356C-Lymphocytic-ILC-ILC-3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ANXA3 CAPG ANKH PDP1 PCNX1 ATG9A MIEF2	6.33e-06	163	189	7	2dbdcbc4c187aad3db837d191cc78662a75dd0b5
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HCAR2 DOCK8 ACO1 WDFY4 ATP10A HCAR3 PNPLA6	8.99e-06	172	189	7	c8ea80042faf923b08ff03d73100533d521d73ef
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HCAR2 CAPG ATP10A ADCY3 ITIH5 KCNA3 PNPLA6	1.12e-05	178	189	7	0b398656f26c4061b11ccf98908d0e2e1367585a
ToppCell	droplet-Liver-Npc-21m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 PCDHB13 HID1 PLXND1 SRGAP1 SCGB1A1 NOS3	1.30e-05	182	189	7	dc55de945c6f78f32eb3a1b3520835eb8417e068
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 PCDHB13 HID1 PLXND1 SRGAP1 SCGB1A1 NOS3	1.30e-05	182	189	7	010a7364da46101cb5068891fd7bc712ea8f13bd
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 PCDHB13 HID1 PLXND1 SRGAP1 SCGB1A1 NOS3	1.30e-05	182	189	7	b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01
ToppCell	Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DOCK8 ACO1 PKD2L1 WDFY4 ATP10A ADCY3 PNPLA6	1.60e-05	188	189	7	d7a9fb5b021e127b8d927658a55a71098d513b5c
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	POLA2 ATP10A ITIH5 KCNA4 DACH2 SRGAP1 FMN2	1.90e-05	193	189	7	3eaa0461618582a1754400624350d269d24e750a
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HCAR2 DOCK8 ACO1 CAPG ITIH5 PNPLA6 HERC5	2.31e-05	199	189	7	8e9862907b15809d083216e7d6a0f435015e5d15
ToppCell	droplet-Kidney-nan-3m-Lymphocytic-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TDRKH NEIL1 POLD1 CAPG WDFY4 DNAH8	3.23e-05	142	189	6	a88bf4bcc80206b16dcc504cc19a3380d01e34a4
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	WDR64 PKD2L1 GBP1 PLA2G4E CYP2G1P DNAH8	3.50e-05	144	189	6	e9d62f202f0fa8747961036ef0eafed91fe8a42f
Disease	polycystic kidney disease 2 (implicated_via_orthology)	PKD2L1 PKD2L2 PKD2	2.27e-07	3	181	3	DOID:0110859 (implicated_via_orthology)
Disease	epilepsy (implicated_via_orthology)	CIT KCNA2 KCNA3 KCNA4 KCNA6 KCNA7 SLC13A5 NOS3	7.94e-06	163	181	8	DOID:1826 (implicated_via_orthology)
Disease	Ciliopathies	DYNC2H1 EVC PKD2 PKHD1 DNAH8 DNAH11	6.19e-05	110	181	6	C4277690
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD2L1 PKD2L2 PKD2	7.86e-05	14	181	3	DOID:898 (implicated_via_orthology)
Disease	Lung diseases	A2M DOCK8 SCGB1A1 PRKDC DNAH11	1.21e-04	78	181	5	C0024115
Disease	Muscle hypotonia	RALGAPA1 INTS1 LETM1	1.45e-04	17	181	3	C0026827
Disease	Ovarian Serous Adenocarcinoma	ERN1 MAP3K4 MAST1	3.67e-04	23	181	3	C1335177
Disease	Choledochal Cyst, Type I	SLC4A2 PKHD1	3.70e-04	5	181	2	C0009439
Disease	Choledochal Cyst, Type II	SLC4A2 PKHD1	3.70e-04	5	181	2	C1257796
Disease	Choledochal Cyst, Type III	SLC4A2 PKHD1	3.70e-04	5	181	2	C1257797
Disease	Choledochal Cyst, Type IV	SLC4A2 PKHD1	3.70e-04	5	181	2	C1257798
Disease	Choledochal Cyst, Type V	SLC4A2 PKHD1	3.70e-04	5	181	2	C1257799
Disease	Choledochal Cyst	SLC4A2 PKHD1	3.70e-04	5	181	2	C0008340
Disease	Intellectual Disability	RALGAPA1 DOCK8 COQ5 RTTN PEX11B LETM1 KCNA2 BRF1 MED23 HTT	4.67e-04	447	181	10	C3714756
Disease	mean corpuscular hemoglobin concentration	HCAR2 STON1 ATR RTTN BEND3 SKI SLC30A1 SLC4A2 NLRP6 HCAR3 KCNA4 BRF1 MTMR3 MAST1 PRKDC ZNF654 PPP6R3	4.85e-04	1105	181	17	EFO_0004528
Disease	acute kidney failure (biomarker_via_orthology)	GPT SCGB1A1 PKD2 NOS3	5.44e-04	61	181	4	DOID:3021 (biomarker_via_orthology)
Disease	VACTERL association (implicated_via_orthology)	DYNC2H1 TBC1D32	5.52e-04	6	181	2	DOID:14679 (implicated_via_orthology)
Disease	serum metabolite measurement	RALGAPA1 TDRD15 UGT1A5 DOK7 TPRKB GLRA3 PKD2L1 GBP1 PDE10A SLC7A6 CIT UGT1A3 ALMS1 RIC1 PPP6R3	7.63e-04	945	181	15	EFO_0005653
Disease	hepatocyte growth factor activator measurement	DOK7 HTT	7.70e-04	7	181	2	EFO_0008152
Disease	metabolite measurement, diet measurement	DOK7 ANKH SCGB1A1 SLC13A5	9.66e-04	71	181	4	EFO_0004725, EFO_0008111
Disease	X-11793--oxidized bilirubin measurement	UGT1A5 UGT1A3	1.02e-03	8	181	2	EFO_0021260
Disease	Succinimide measurement	UGT1A5 UGT1A3	1.02e-03	8	181	2	EFO_0022118
Disease	X-11530 measurement	UGT1A5 UGT1A3	1.02e-03	8	181	2	EFO_0021249
Disease	Urologic Neoplasms	ATR OGG1	1.02e-03	8	181	2	C0042076
Disease	sulfate of piperine metabolite C16H19NO3 (2) measurement	UGT1A5 UGT1A3	1.02e-03	8	181	2	EFO_0801034
Disease	cholelithiasis, bilirubin measurement	UGT1A5 UGT1A3	1.02e-03	8	181	2	EFO_0004570, EFO_0004799
Disease	X-11522 measurement	UGT1A5 UGT1A3	1.02e-03	8	181	2	EFO_0800696
Disease	X-10458 measurement	UGT1A5 UGT1A3	1.02e-03	8	181	2	EFO_0800692
Disease	X-24849 measurement	UGT1A5 UGT1A3	1.02e-03	8	181	2	EFO_0800909
Disease	Cancer of Urinary Tract	ATR OGG1	1.02e-03	8	181	2	C0751571
Disease	membrane-associated progesterone receptor component 1 measurement	UGT1A5 UGT1A3	1.02e-03	8	181	2	EFO_0802740
Disease	X-16946 measurement	UGT1A5 UGT1A3	1.02e-03	8	181	2	EFO_0800766
Disease	HMG CoA reductase inhibitor use measurement	TDRD15 HMGCR SKI PCNX1 NOS3 DNAH11	1.13e-03	189	181	6	EFO_0009932
Disease	Disproportionate short stature	DYNC2H1 EVC EXT2 ANKH	1.31e-03	77	181	4	C0878659
Disease	X-11442 measurement	UGT1A5 UGT1A3	1.31e-03	9	181	2	EFO_0021236
Disease	X-11441 measurement	UGT1A5 UGT1A3	1.31e-03	9	181	2	EFO_0021235
Disease	circulating cell free DNA measurement	UGT1A5 UGT1A3	1.31e-03	9	181	2	EFO_0004739
Disease	sulfate of piperine metabolite C18H21NO3 (3) measurement	UGT1A5 UGT1A3	1.31e-03	9	181	2	EFO_0801037
Disease	sulfate of piperine metabolite C18H21NO3 (1) measurement	UGT1A5 UGT1A3	1.31e-03	9	181	2	EFO_0801036
Disease	X-11880 measurement	UGT1A5 UGT1A3	1.31e-03	9	181	2	EFO_0800698
Disease	centronuclear myopathy X-linked (implicated_via_orthology)	MTM1 MTMR3	1.31e-03	9	181	2	DOID:0111225 (implicated_via_orthology)
Disease	protein-tyrosine kinase 6 measurement	UGT1A5 UGT1A3	1.31e-03	9	181	2	EFO_0020691
Disease	testis-specific chromodomain protein Y 1 measurement	UGT1A5 UGT1A3	1.31e-03	9	181	2	EFO_0802127
Disease	Autosomal Recessive Polycystic Kidney Disease	SLC4A2 PKHD1	1.31e-03	9	181	2	C0085548
Disease	bilirubin measurement, response to xenobiotic stimulus	UGT1A5 UGT1A3	1.31e-03	9	181	2	EFO_0004570, GO_0009410
Disease	myocardial infarction	TDRD15 TDRKH STON1 DYNC2H1 HMGCR SKI NOS3 HTT	1.50e-03	350	181	8	EFO_0000612
Disease	Cataract	MYH9 INTS1 ALDH3A1	1.51e-03	37	181	3	C0086543
Disease	bilirubin measurement, response to tenofovir	UGT1A5 UGT1A3	1.63e-03	10	181	2	EFO_0004570, EFO_0009279
Disease	X-21448 measurement	UGT1A5 UGT1A3	1.63e-03	10	181	2	EFO_0800816
Disease	UDP-glucuronosyltransferase 1-6 measurement	UGT1A5 UGT1A3	1.63e-03	10	181	2	EFO_0802185
Disease	X-23974 measurement	UGT1A5 UGT1A3	1.63e-03	10	181	2	EFO_0800867
Disease	Cleft palate, cleft lip	TDRD15 MYH9 STON1 KCNA2 PDP1 MTMR3 PKHD1	1.74e-03	279	181	7	EFO_0003959, HP_0000175
Disease	Inherited neuropathies	SPG11 PNPLA6 ZFYVE26	1.90e-03	40	181	3	C0598589
Disease	autosomal recessive polycystic kidney disease (biomarker_via_orthology)	SLC4A2 PKHD1	1.98e-03	11	181	2	DOID:0110861 (biomarker_via_orthology)
Disease	histidine betaine (hercynine) measurement	UGT1A5 UGT1A3	1.98e-03	11	181	2	EFO_0800972
Disease	X-21796 measurement	UGT1A5 UGT1A3	1.98e-03	11	181	2	EFO_0800825
Disease	insomnia, bilirubin measurement	UGT1A5 UGT1A3	1.98e-03	11	181	2	EFO_0004570, EFO_0004698
Disease	aldosterone measurement	UGT1A5 UGT1A3	1.98e-03	11	181	2	EFO_0010219
Disease	venous thromboembolism, response to antineoplastic agent	OVCH2 PKHD1 RIC1	2.04e-03	41	181	3	EFO_0004286, GO_0097327
Disease	depressive symptom measurement, response to antidepressant	WDR64 WDFY4 ADCY3 ARHGAP22	2.14e-03	88	181	4	EFO_0007006, GO_0036276
Disease	Huntington Disease, Late Onset	OGG1 HTT	2.37e-03	12	181	2	C0393574
Disease	p-cresol glucuronide measurement	UGT1A5 UGT1A3	2.37e-03	12	181	2	EFO_0800079
Disease	Oligospermia	DICER1 NOS3	2.37e-03	12	181	2	C0028960
Disease	biliverdin measurement	UGT1A5 UGT1A3	2.37e-03	12	181	2	EFO_0021033
Disease	Akinetic-Rigid Variant of Huntington Disease	OGG1 HTT	2.37e-03	12	181	2	C0751207
Disease	Juvenile Huntington Disease	OGG1 HTT	2.37e-03	12	181	2	C0751208
Disease	sleep duration, low density lipoprotein cholesterol measurement	TDRD15 HMGCR PLCG1 HTT	2.42e-03	91	181	4	EFO_0004611, EFO_0005271
Disease	complement factor D measurement	RTTN PIKFYVE SLC30A5 LRRTM4	2.61e-03	93	181	4	EFO_0020283
Disease	apolipoprotein B measurement	TDRD15 UGT1A5 DOK7 PKD2L1 HMGCR UGT1A3 KCNA4 EPS8L3 PLCG1 HTT DNAH11	2.74e-03	663	181	11	EFO_0004615
Disease	retinol dehydrogenase 16 measurement	UGT1A5 UGT1A3	2.79e-03	13	181	2	EFO_0802007
Disease	phospholipids in medium LDL measurement	TDRD15 DOK7 HMGCR	3.40e-03	49	181	3	EFO_0022183
Disease	anemia (implicated_via_orthology)	SLC4A2 SLC4A11	3.73e-03	15	181	2	DOID:2355 (implicated_via_orthology)
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	TDRD15 HMGCR PLCG1	3.81e-03	51	181	3	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	diglyceride measurement	DOK7 PKD2L1 PDE10A	3.81e-03	51	181	3	EFO_0010223
Disease	type 2 diabetes mellitus (implicated_via_orthology)	HMGCR PPP1CA PPP1CC ALMS1	4.05e-03	105	181	4	DOID:9352 (implicated_via_orthology)
Disease	alkaline phosphatase measurement	RALGAPA1 TDRD15 ERN1 DOK7 EVC PKD2L1 SLC30A1 SLC30A5 CYP2G1P SCGB1A1 PKD2 FMN2 SLC13A5 RIC1	4.09e-03	1015	181	14	EFO_0004533
Disease	Diabetic Angiopathies	ADCY3 NOS3	4.24e-03	16	181	2	C0011875
Disease	Microangiopathy, Diabetic	ADCY3 NOS3	4.24e-03	16	181	2	C0025945
Disease	Familial thoracic aortic aneurysm and aortic dissection	SKI PKD2 MED12	4.25e-03	53	181	3	C4707243
Disease	low density lipoprotein cholesterol measurement, body fat percentage	UGT1A5 UGT1A3	4.79e-03	17	181	2	EFO_0004611, EFO_0007800
Disease	Huntington Disease	OGG1 HTT	4.79e-03	17	181	2	C0020179
Disease	Lipidemias	NEIL1 NOS3	4.79e-03	17	181	2	C1706412
Disease	Hyperlipidemia	NEIL1 NOS3	4.79e-03	17	181	2	C0020473
Disease	Prostatic Neoplasms	ATR ANXA3 OGG1 SLC4A2 PDP1 SENP6 EPS8L3 PRKDC NOS3 MED12	4.91e-03	616	181	10	C0033578
Disease	Malignant neoplasm of prostate	ATR ANXA3 OGG1 SLC4A2 PDP1 SENP6 EPS8L3 PRKDC NOS3 MED12	4.91e-03	616	181	10	C0376358
Disease	nevus count	DOCK8 SLC30A1	5.37e-03	18	181	2	EFO_0004632
Disease	angiopoietin-related protein 1 measurement	UGT1A5 UGT1A3	5.37e-03	18	181	2	EFO_0801382
Disease	immature platelet fraction	DOCK8 RTTN BRF1 TBC1D14	5.41e-03	114	181	4	EFO_0009187
Disease	urate measurement, spine bone mineral density	UGT1A5 UGT1A3 RIC1	5.47e-03	58	181	3	EFO_0004531, EFO_0007701
Disease	Polydactyly	DYNC2H1 EVC PNPLA6 ALMS1	5.93e-03	117	181	4	C0152427
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	TDRD15 HCAR2 SPG11 HMGCR HCAR3 HTT	5.93e-03	264	181	6	EFO_0008317, EFO_0020944
Disease	DiGeorge syndrome (implicated_via_orthology)	PLXND1 DICER1	5.97e-03	19	181	2	DOID:11198 (implicated_via_orthology)
Disease	migraine disorder, type 2 diabetes mellitus	SKI CIT SENP6	6.01e-03	60	181	3	MONDO_0005148, MONDO_0005277

Protein segments in the cluster

Peptide	Gene	Start	Entry
FCSETIDIIQPALVL	TMEM62	81	Q0P6H9
SIPTVFFLRNIPCDL	UGT1A3	166	P35503
PFSIRVLLEAAIRNC	ACO1	36	P21399
FLRQVLALCVNPDLL	GPT	81	P24298
RDALDPQCLAAVIFI	SLC4A2	701	P04920
DRILKFCAQTFLLSP	TBC1D32	231	Q96NH3
RLERIFEACFPSILV	AFTPH	651	Q6ULP2
PIVCVRSLEEAIQFI	ALDH3A1	341	P30838
VAIADLLLIFCLPFR	GPR34	96	Q9UPC5
PDLPSCIFLEQRELF	ALMS1	2916	Q8TCU4
LCLRSFPQLKLTFDE	ANXA3	201	P12429
PARVIVLLQEFCNLF	DNAH11	381	Q96DT5
LVQRSTLDLILFCFP	DOP1A	241	Q5JWR5
ALLFEVTQCRPSAAL	AP5Z1	676	O43299
SPFTNILCGIIFVER	DICER1	436	Q9UPY3
QELICLPQVFDLFLK	DACH2	86	Q96NX9
LLAENERLLCFSPAL	CDAN1	391	Q8IWY9
ILDALFVLFEECSQP	CIT	51	O14578
LRCNEIFPADILLLS	ATP10A	171	O60312
CIRVSVQLEASPAFL	A2M	821	P01023
RLSCVDPFINELVLF	OR5K2	186	Q8NHB8
NAREQLEVLFPFCVV	RIC1	806	Q4ADV7
LEVLFPFCVVERTSQ	RIC1	811	Q4ADV7
ISRACFPLAFLIFNI	GLRA3	431	O75311
LNPLSFQCEFVKLRI	INTS7	611	Q9NVH2
LEIIFSRFGPIRSCE	PPIL4	256	Q8WUA2
LACRLLVQLFPELFS	BEND3	266	Q5T5X7
FACLLSVPILFEETF	ANKRD27	86	Q96NW4
LQAAPVLFCALRAVD	OVOS1	516	Q6IE37
SEVQPFLRVPLLCDF	RB1CC1	591	Q8TDY2
EPCVLRFQVLLESPF	PCDHB13	101	Q9Y5F0
PLIFTLRAQRDCTFL	PNPLA6	591	Q8IY17
IIPRFCEDLFSQVAR	KIF14	466	Q15058
RVPVFTAPFCQALLE	OGFOD2	141	Q6N063
SIVSFCLETLPIFRD	KCNA2	176	P16389
LESVLRNCQDFFPVI	MAGEA2	136	P43356
TVPIRVFQDCRNLDF	LRRTM4	171	Q86VH4
AFDRPICEALLDQRF	NEIL1	156	Q96FI4
CTVDNPVLERFISLF	RASGRP2	186	Q7LDG7
VDFPLSRLTVCFNID	ITIH5	686	Q86UX2
RNFFLRLCSEVPILE	INTS1	636	Q8N201
AISLVFAVIPFCRDV	MFSD4A	91	Q8N468
FNFCSPETVREEVLL	PNLIP	446	P16233
EFFLPLGIILFCSAR	HCAR2	196	Q8TDS4
CAPVIERLRFLFNEL	HERC2	1506	O95714
FFPACVSLVLELSRE	HMGCR	211	P04035
FAIDCLESVFTIRPA	CFAP65	501	Q6ZU64
VFVRALINDSLFILC	GPR137C	201	Q8N3F9
RICADLFRLVPFLVF	LETM1	201	O95202
RLLFPRLSLLVCEQF	LINC02901	171	Q4VX62
LEQASIRFQCVFLPD	TMEM63C	526	Q9P1W3
ISARDLVIVFTLCFP	PCNX1	1111	Q96RV3
LRETVGEPFFLLLCA	PLXND1	1506	Q9Y4D7
QCIPLFVEAALERLT	IPO7	756	O95373
RQFFCNIPQLLSLLD	OR14L1P	176	Q8NHC6
PNVIDSFFCDLPLVI	OR4K13	171	Q8NH42
QFTLPVRLCKEIELF	PDE10A	451	Q9Y233
CFDEFNRIELPVLSV	DNAH8	1896	Q96JB1
ILFKSLNFILARCPE	EPS8L3	316	Q8TE67
VFELANSIVLPFDCR	FOLH1B	276	Q9HBA9
FGNVCLRFLPVFDIV	MED23	956	Q9ULK4
ISIVIFCLETLPEFR	KCNA3	246	P22001
VEFFNLVLLFCELIR	MED12	591	Q93074
RCSALLQVIFSPLEE	GBP1	406	P32455
FIDFGLDLQPCIDLI	MYH9	501	P35579
LRNLAQIFLEDFCSP	ARMC7	156	Q9H6L4
RLLRQDPIECLFSFI	OGG1	131	O15527
VPVQEILDFICRTLS	PELP1	336	Q8IZL8
KFESPNILRIFGICI	MLKL	256	Q8NB16
LEISFTSVCNPRFLI	OR6C76	66	A6NM76
QLFFPLIRNCELSRI	PDP1	6	Q9P0J1
FREACIELLPQTFQI	GPR45	331	Q9Y5Y3
CFQEVPASLLELRAL	LRRC58	131	Q96CX6
IISRPARLLECLEFN	MAST1	281	Q9Y2H9
PPCTLRQALTFFLDI	NOS3	851	P29474
FRCPTLLEVLEQFPS	NOS3	906	P29474
CPINDLNVILLFLRA	PANX3	321	Q96QZ0
RDPIRALTCFSVLFL	HERC5	986	Q9UII4
FNCLPIAAIVDEKIF	PPP1CA	156	P62136
VRLGFSLCPAELEFL	PLA2G4E	331	Q3MJ16
CFQEVTLVLDSPFLE	FANCD2OS	51	Q96PS1
FTCIDPIVLQEREFL	PIKFYVE	721	Q9Y2I7
ENALVILQSRVCPFL	DYNC2H1	3266	Q8NCM8
CVFLLTLFPRRIFLE	ATR	636	Q13535
CEARVVARILPQFLD	HTT	2971	P42858
QAVDQLSLFRPLCKF	ILVBL	161	A1L0T0
ISIVIFCLETLPQFR	KCNA6	186	P17658
SIVVFCLETLPDFRD	KCNA7	156	Q96RP8
IILDALPQLCDFTVA	DOCK8	1221	Q8NF50
VLRCQLSAEEVRFPV	C2CD2L	151	O14523
ILPECFSFADREVQL	ERN1	601	O75460
VCRAFSALVDQIALP	DYTN	561	A2CJ06
DFLVLFFCLPIVIFN	GPR37L1	176	O60883
IFCLRPRALEIIDFF	ATG9A	491	Q7Z3C6
EQIFGLIRCPFVENT	C3orf38	251	Q5JPI3
FLRVPVNDSFCEKIL	DUSP16	206	Q9BY84
LRLFQPFGVIDECTV	CELF5	151	Q8N6W0
VFTPEEAVNFILSCL	ILKAP	331	Q9H0C8
VLPTEENFLLLFRCQ	CALB1	81	P05937
FAFAELCVVPLRIFS	ANKH	361	Q9HCJ1
ETLLVLVVFAALFDC	ADCY3	76	O60266
RFLCLEFSQVNNPLI	COQ5	241	Q5HYK3
PFALELLISDDCFVL	CAPG	271	P40121
AVLLREFVGCFIDFP	ECI2	221	O75521
VLLLRFVDDCLLSVF	ERMARD	396	Q5T6L9
EEFIPLAQRLTCKFL	EME1	91	Q96AY2
TFLRVNAFPEVLACE	EVC	191	P57679
QISFLFDCIVRGISP	DOK7	191	Q18PE1
LSLIPNFSERVFCIL	FMN2	1441	Q9NZ56
PLLLDVVRNACDLFI	PEX11B	206	O96011
LFPLFQILDSRQVCV	SLC13A5	66	Q86YT5
PLSFAEINVLICFFL	SLC13A5	311	Q86YT5
RIAPLRVLSFDIECA	POLD1	306	P28340
DAFVRQALCRFPELA	NLRP6	631	P59044
VPLQLIESVECRDIF	MTMR3	71	Q13615
AFLLDPDRCVVQRLL	HGH1	191	Q9BTY7
EPCVLRFQVLLESPF	PCDHB8	101	Q9UN66
FQVILSDRPCLELSA	PLEKHM2	841	Q8IWE5
IRFLPNGCFIEDILQ	OGFR	101	Q9NZT2
QIDDFLCEVPSLIRL	OR2H1	171	Q9GZK4
QVDHFFCEVPALLRL	OR2J3	176	O76001
CELVATFLNISIPLD	MROH5	811	Q6ZUA9
SFEPAFLVLCRVLLN	MAP3K4	611	Q9Y6R4
APLCLTLQERLLAFE	MIEF2	121	Q96C03
QFCVSILESAVPLLR	RTTN	381	Q86VV8
QCATIQLDFQLPIRF	TARS3	636	A2RTX5
ELLSRLGEFEQFCPV	AK9	1631	Q5TCS8
SFPFNVEICRINIDL	UBOX5	56	O94941
ENSCEVRFVILVLAP	SLC4A11	226	Q8NBS3
EVFLRQSPLEPCLVF	TRMT2B	206	Q96GJ1
LRQFLSTCVDIPDAI	TIGD6	476	Q17RP2
LFPKERFNDLISCIR	SRGAP1	591	Q7Z6B7
RREFFNLPSEVLGCV	TDRD6	116	O60522
CLPQVLNSVLREFTL	SKIL	166	P12757
VLIEDLCAINPRFLL	TDRD15	841	B5MCY1
LVACLPDVVLQELFF	HPS3	786	Q969F9
ICLPELREQFEAGFI	OVCH2	161	Q7RTZ1
DLEIPLFFCELAQVI	OR7G2	171	Q8NG99
EFFLPLGIILFCSAR	HCAR3	196	P49019
LLAIADLLFCPDFTV	HID1	146	Q8IV36
RLQPLFDCLLTIVVN	HID1	476	Q8IV36
VNAILPALSRCFELT	PRAMEF20	366	Q5VT98
ERCRFLLFVVDLSQP	MTG2	301	Q9H4K7
ALRSVPCDVFPVFLD	PKHD1	71	P08F94
RADFQLCFVVLEKTP	ARHGAP5	371	Q13017
SPFEDIFKQCLRTII	POLA2	396	Q14181
EVCAPVIERLRFLFN	HERC2P3	231	Q9BVR0
RFLFNELRPAVCNDL	HERC2P3	241	Q9BVR0
GALFRCPVVFRQEIL	ITGAL	1016	P20701
CFLLQLFSELTRPEF	URB1	1641	O60287
FLEVIFTTVCIPRFL	OR6C6	66	A6NF89
LCLPQILNSVLRDFS	SKI	121	P12755
LAPLLVEQCVDFIRE	ARHGAP22	171	Q7Z5H3
TELGCLRAIILFNPD	RXRB	436	P28702
NFSLCSLVPLVDIDI	CYP2G1P	111	Q6ZSU1
LFNLDVPESRRCFVK	CILP	741	O75339
QLPLIIVCDRFDFVH	CLTC	771	Q00610
IIFPERDAAIRVLNC	SPG11	176	Q96JI7
RDAAIRVLNCFTLPL	SPG11	181	Q96JI7
IKLDISRTFPNLCIF	TBC1D14	466	Q9P2M4
AEICPSFQRVIETLL	SCGB1A1	21	P11684
NETITKFLQLCIFPR	THOC2	971	Q8NI27
LEAPVVARAALFLEC	UNC80	1211	Q8N2C7
VTEIFRQAFLLPICE	RALGAPA1	411	Q6GYQ0
SLPFQAIECSLARIA	TDRKH	411	Q9Y2W6
DADRSPIFLQFIDCV	MTM1	431	Q13496
FEQSRIIKFVPLDAC	STON1	496	Q9Y6Q2
LCLFPRVFAAEAVTA	TIMMDC1	16	Q9NPL8
DINRACLFVPSIDVL	EXT2	146	Q93063
IICFPSLQRLAEDVS	WDFY4	86	Q6ZS81
NDLEILRICALSIFF	ZNF654	386	Q8IZM8
SIPAVFFLRNIPCDL	UGT1A5	166	P35504
LCRVSLPEFQQFLLD	PLCG1	246	P19174
FRLLIEPVIFCLDFI	SENP6	456	Q9GZR1
FAFGIVLCELIARVP	TESK1	241	Q15569
NVNLFCIIRLVAEFP	PKD2L2	241	Q9NZM6
CVFLVDSELFRESPV	RPAP1	1161	Q9BWH6
ANINLFCVVRLLVEF	PKD2	431	Q13563
FNCLPIAAIVDEKIF	PPP1CC	156	P36873
NINLFCVLRLVVEFP	PKD2L1	311	Q9P0L9
TFLLLARELCINAPA	BRF1	166	Q92994
RALQLVQFDCSPELF	PIAS4	41	Q8N2W9
SAFINLVEFCREILP	PRKDC	621	P78527
FPVLLRLACDVDQVT	PRKDC	966	P78527
IERFTPIPALLFNCT	SLC7A6	361	Q92536
VPFLLLDKRDVVSCF	TOR4A	361	Q9NXH8
LQDFCLPFLRITSLL	UBR3	1646	Q6ZT12
FIIAVICLLLFDNDD	SLC30A5	156	Q8TAD4
QLVIFLLDFCTLDIP	ZZEF1	1036	O43149
GLCFAILLEAIERFI	SLC30A1	91	Q9Y6M5
QVEICIALILASPFE	PPP6R3	391	Q5H9R7
CERLLEQFPLFEAFL	ZFYVE26	1356	Q68DK2
QLDLFPECRVTLLLF	TPRKB	6	Q9Y3C4
FELSQTRDFILPCDV	WDR64	911	B1ANS9
RIDLTPFLVDCANTL	ZAN	2156	Q9Y493
IVIFCLETLPEFRDD	KCNA4	321	P22459
LAFCALLPEDLRFLA	LRRC14	316	Q15048
LPLREFDCITTDFVL	LGI3	211	Q8N145